CN108077911A - A kind of epileptic's tailored version clinical nutrition formula and preparation method thereof - Google Patents
A kind of epileptic's tailored version clinical nutrition formula and preparation method thereof Download PDFInfo
- Publication number
- CN108077911A CN108077911A CN201711331581.7A CN201711331581A CN108077911A CN 108077911 A CN108077911 A CN 108077911A CN 201711331581 A CN201711331581 A CN 201711331581A CN 108077911 A CN108077911 A CN 108077911A
- Authority
- CN
- China
- Prior art keywords
- parts
- vitamin
- powder
- epileptic
- clinical nutrition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 32
- 230000035764 nutrition Effects 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 230000001037 epileptic effect Effects 0.000 title claims description 31
- 238000009472 formulation Methods 0.000 title description 9
- 239000011782 vitamin Substances 0.000 claims abstract description 34
- 229940088594 vitamin Drugs 0.000 claims abstract description 32
- 229930003231 vitamin Natural products 0.000 claims abstract description 32
- 235000013343 vitamin Nutrition 0.000 claims abstract description 32
- 235000013305 food Nutrition 0.000 claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 19
- 235000012054 meals Nutrition 0.000 claims abstract description 18
- 230000035622 drinking Effects 0.000 claims abstract description 17
- 235000008216 herbs Nutrition 0.000 claims abstract description 17
- 230000010354 integration Effects 0.000 claims abstract description 17
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 15
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 15
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 13
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 12
- 239000004615 ingredient Substances 0.000 claims abstract description 12
- 239000011573 trace mineral Substances 0.000 claims abstract description 9
- 235000013619 trace mineral Nutrition 0.000 claims abstract description 9
- 239000000843 powder Substances 0.000 claims description 79
- 235000013350 formula milk Nutrition 0.000 claims description 29
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 24
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 23
- 235000019197 fats Nutrition 0.000 claims description 18
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 16
- 235000015097 nutrients Nutrition 0.000 claims description 16
- 241000237502 Ostreidae Species 0.000 claims description 14
- 235000020636 oyster Nutrition 0.000 claims description 14
- 235000018102 proteins Nutrition 0.000 claims description 14
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 12
- 235000010469 Glycine max Nutrition 0.000 claims description 12
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims description 12
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims description 11
- 244000068988 Glycine max Species 0.000 claims description 11
- 235000014633 carbohydrates Nutrition 0.000 claims description 11
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 10
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 10
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 10
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 10
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 10
- 244000203593 Piper nigrum Species 0.000 claims description 10
- 235000008184 Piper nigrum Nutrition 0.000 claims description 10
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 10
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 10
- 241000196324 Embryophyta Species 0.000 claims description 9
- 244000197580 Poria cocos Species 0.000 claims description 9
- 235000008599 Poria cocos Nutrition 0.000 claims description 9
- 235000013614 black pepper Nutrition 0.000 claims description 9
- 244000144730 Amygdalus persica Species 0.000 claims description 8
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 8
- 229930003268 Vitamin C Natural products 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 235000019154 vitamin C Nutrition 0.000 claims description 8
- 239000011718 vitamin C Substances 0.000 claims description 8
- 241000251468 Actinopterygii Species 0.000 claims description 7
- 235000013339 cereals Nutrition 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 7
- 239000000839 emulsion Substances 0.000 claims description 7
- 239000000835 fiber Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 6
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 6
- 229930003427 Vitamin E Natural products 0.000 claims description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 6
- 235000013312 flour Nutrition 0.000 claims description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 6
- 235000019155 vitamin A Nutrition 0.000 claims description 6
- 239000011719 vitamin A Substances 0.000 claims description 6
- 239000011716 vitamin B2 Substances 0.000 claims description 6
- 239000011726 vitamin B6 Substances 0.000 claims description 6
- 235000019165 vitamin E Nutrition 0.000 claims description 6
- 239000011709 vitamin E Substances 0.000 claims description 6
- 229940046009 vitamin E Drugs 0.000 claims description 6
- 229940045997 vitamin a Drugs 0.000 claims description 6
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 5
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 5
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 5
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 5
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 5
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 5
- 235000013734 beta-carotene Nutrition 0.000 claims description 5
- 239000011648 beta-carotene Substances 0.000 claims description 5
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 5
- 229960002747 betacarotene Drugs 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 5
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 claims description 5
- 229960000304 folic acid Drugs 0.000 claims description 5
- 235000019152 folic acid Nutrition 0.000 claims description 5
- 239000011724 folic acid Substances 0.000 claims description 5
- 235000001968 nicotinic acid Nutrition 0.000 claims description 5
- 229960003512 nicotinic acid Drugs 0.000 claims description 5
- 239000011664 nicotinic acid Substances 0.000 claims description 5
- 229940055726 pantothenic acid Drugs 0.000 claims description 5
- 235000019161 pantothenic acid Nutrition 0.000 claims description 5
- 239000011713 pantothenic acid Substances 0.000 claims description 5
- 239000011691 vitamin B1 Substances 0.000 claims description 5
- 239000011715 vitamin B12 Substances 0.000 claims description 5
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 4
- 229920001353 Dextrin Polymers 0.000 claims description 4
- 239000004375 Dextrin Substances 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 229920001202 Inulin Polymers 0.000 claims description 4
- 229920002752 Konjac Polymers 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 235000019425 dextrin Nutrition 0.000 claims description 4
- 235000013399 edible fruits Nutrition 0.000 claims description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 4
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 4
- 229940029339 inulin Drugs 0.000 claims description 4
- 239000003094 microcapsule Substances 0.000 claims description 4
- 235000010755 mineral Nutrition 0.000 claims description 4
- 239000011707 mineral Substances 0.000 claims description 4
- 235000021281 monounsaturated fatty acids Nutrition 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims description 4
- 241000238557 Decapoda Species 0.000 claims description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 3
- 244000061456 Solanum tuberosum Species 0.000 claims description 3
- 235000013594 poultry meat Nutrition 0.000 claims description 3
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 claims description 2
- 229920000858 Cyclodextrin Polymers 0.000 claims description 2
- 229920002307 Dextran Polymers 0.000 claims description 2
- 241000208688 Eucommia Species 0.000 claims description 2
- 229920001503 Glucan Polymers 0.000 claims description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 2
- 108010001441 Phosphopeptides Proteins 0.000 claims description 2
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 claims description 2
- 241000219780 Pueraria Species 0.000 claims description 2
- 240000002547 Rosa roxburghii Species 0.000 claims description 2
- 235000000640 Rosa roxburghii Nutrition 0.000 claims description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 2
- 229960002685 biotin Drugs 0.000 claims description 2
- 235000020958 biotin Nutrition 0.000 claims description 2
- 239000011616 biotin Substances 0.000 claims description 2
- 239000005018 casein Substances 0.000 claims description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 2
- 235000021240 caseins Nutrition 0.000 claims description 2
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 claims description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 2
- 229960001231 choline Drugs 0.000 claims description 2
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 2
- 235000020243 first infant milk formula Nutrition 0.000 claims description 2
- 229930003944 flavone Natural products 0.000 claims description 2
- 150000002213 flavones Chemical class 0.000 claims description 2
- 235000011949 flavones Nutrition 0.000 claims description 2
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 2
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 2
- 229960000367 inositol Drugs 0.000 claims description 2
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 claims description 2
- 150000002632 lipids Chemical class 0.000 claims description 2
- 239000011812 mixed powder Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 239000011772 phylloquinone Substances 0.000 claims description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 2
- 206010015037 epilepsy Diseases 0.000 abstract description 32
- 230000000694 effects Effects 0.000 abstract description 22
- 235000009200 high fat diet Nutrition 0.000 abstract description 21
- 238000002560 therapeutic procedure Methods 0.000 abstract description 12
- 208000002877 Epileptic Syndromes Diseases 0.000 abstract description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 12
- 230000003556 anti-epileptic effect Effects 0.000 description 12
- 239000001961 anticonvulsive agent Substances 0.000 description 12
- 239000011575 calcium Substances 0.000 description 12
- 229910052791 calcium Inorganic materials 0.000 description 12
- 229960005069 calcium Drugs 0.000 description 12
- 208000024891 symptom Diseases 0.000 description 12
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 12
- 230000002708 enhancing effect Effects 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 9
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 9
- 230000036039 immunity Effects 0.000 description 9
- 239000011777 magnesium Substances 0.000 description 9
- 229910052749 magnesium Inorganic materials 0.000 description 9
- 229940091250 magnesium supplement Drugs 0.000 description 9
- 208000001654 Drug Resistant Epilepsy Diseases 0.000 description 8
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- 206010010904 Convulsion Diseases 0.000 description 7
- 229920002774 Maltodextrin Polymers 0.000 description 7
- 239000005913 Maltodextrin Substances 0.000 description 7
- 235000010489 acacia gum Nutrition 0.000 description 7
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 7
- 229940024606 amino acid Drugs 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- 210000004556 brain Anatomy 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 229940035034 maltodextrin Drugs 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- 241000206575 Chondrus crispus Species 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 108010073771 Soybean Proteins Proteins 0.000 description 6
- 239000005862 Whey Substances 0.000 description 6
- 102000007544 Whey Proteins Human genes 0.000 description 6
- 108010046377 Whey Proteins Proteins 0.000 description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 235000019688 fish Nutrition 0.000 description 6
- 229910052742 iron Inorganic materials 0.000 description 6
- 239000002858 neurotransmitter agent Substances 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 235000019710 soybean protein Nutrition 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 229960003080 taurine Drugs 0.000 description 6
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 6
- 229910052725 zinc Inorganic materials 0.000 description 6
- 239000011701 zinc Substances 0.000 description 6
- 108010038807 Oligopeptides Proteins 0.000 description 5
- 102000015636 Oligopeptides Human genes 0.000 description 5
- 229930003316 Vitamin D Natural products 0.000 description 5
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 235000013373 food additive Nutrition 0.000 description 5
- 239000002778 food additive Substances 0.000 description 5
- 235000003132 food thickener Nutrition 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 235000019166 vitamin D Nutrition 0.000 description 5
- 239000011710 vitamin D Substances 0.000 description 5
- 150000003710 vitamin D derivatives Chemical class 0.000 description 5
- 229940046008 vitamin d Drugs 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 4
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 4
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 4
- 244000000626 Daucus carota Species 0.000 description 4
- 235000002767 Daucus carota Nutrition 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 235000004347 Perilla Nutrition 0.000 description 4
- 244000124853 Perilla frutescens Species 0.000 description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 4
- 235000011453 Vigna umbellata Nutrition 0.000 description 4
- 240000001417 Vigna umbellata Species 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 235000010419 agar Nutrition 0.000 description 4
- 229960003965 antiepileptics Drugs 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000003240 coconut oil Substances 0.000 description 4
- 235000019864 coconut oil Nutrition 0.000 description 4
- 235000021277 colostrum Nutrition 0.000 description 4
- 210000003022 colostrum Anatomy 0.000 description 4
- NIJJYAXOARWZEE-UHFFFAOYSA-N di-n-propyl-acetic acid Natural products CCCC(C(O)=O)CCC NIJJYAXOARWZEE-UHFFFAOYSA-N 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 239000003292 glue Substances 0.000 description 4
- 239000004519 grease Substances 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 239000004006 olive oil Substances 0.000 description 4
- 235000008390 olive oil Nutrition 0.000 description 4
- 229910052698 phosphorus Inorganic materials 0.000 description 4
- 239000011574 phosphorus Substances 0.000 description 4
- 239000011435 rock Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- MSRILKIQRXUYCT-UHFFFAOYSA-M valproate semisodium Chemical compound [Na+].CCCC(C(O)=O)CCC.CCCC(C([O-])=O)CCC MSRILKIQRXUYCT-UHFFFAOYSA-M 0.000 description 4
- 229960000604 valproic acid Drugs 0.000 description 4
- 239000011647 vitamin D3 Substances 0.000 description 4
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 4
- 235000008939 whole milk Nutrition 0.000 description 4
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 3
- 108010011485 Aspartame Proteins 0.000 description 3
- 102000040350 B family Human genes 0.000 description 3
- 108091072128 B family Proteins 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- 229920002907 Guar gum Polymers 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- -1 K-IAO Chemical compound 0.000 description 3
- 208000001132 Osteoporosis Diseases 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 244000098338 Triticum aestivum Species 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000000605 aspartame Substances 0.000 description 3
- 235000010357 aspartame Nutrition 0.000 description 3
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 3
- 229960003438 aspartame Drugs 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000004097 bone metabolism Effects 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 230000001804 emulsifying effect Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000000665 guar gum Substances 0.000 description 3
- 235000010417 guar gum Nutrition 0.000 description 3
- 229960002154 guar gum Drugs 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 235000003642 hunger Nutrition 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 210000002569 neuron Anatomy 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
- 229920000053 polysorbate 80 Polymers 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 230000037351 starvation Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 2
- 206010001497 Agitation Diseases 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 244000247812 Amorphophallus rivieri Species 0.000 description 2
- 235000001206 Amorphophallus rivieri Nutrition 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 2
- 229920002581 Glucomannan Polymers 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- 206010020850 Hyperthyroidism Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 102000004895 Lipoproteins Human genes 0.000 description 2
- 108090001030 Lipoproteins Proteins 0.000 description 2
- 229920000161 Locust bean gum Polymers 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 240000005809 Prunus persica Species 0.000 description 2
- 206010053260 Secondary hyperthyroidism Diseases 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 210000005013 brain tissue Anatomy 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000004880 explosion Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 229940046240 glucomannan Drugs 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000000252 konjac Substances 0.000 description 2
- 235000010485 konjac Nutrition 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 235000010420 locust bean gum Nutrition 0.000 description 2
- 239000000711 locust bean gum Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000000803 paradoxical effect Effects 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 230000036280 sedation Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- 229940034208 thyroxine Drugs 0.000 description 2
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- DBOVHQOUSDWAPQ-UHFFFAOYSA-N (4aS)-6c-[O2-(3,5,3'-trihydroxy-biphenyl-2-carbonyl)-beta-D-glucopyranosyloxy]-5t-vinyl-(4ar)-4,4a,5,6-tetrahydro-3H-pyrano[3,4-c]pyran-1-one Natural products OC1C(O)C(CO)OC(OC2C(C3C(C(OCC3)=O)=CO2)C=C)C1OC(=O)C1=C(O)C=C(O)C=C1C1=CC=CC(O)=C1 DBOVHQOUSDWAPQ-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- RANQPHKSRUUPKK-UHFFFAOYSA-N 3-O-[alpha-L-arabinofuranosyl-(1->2)-O-{beta-D-glucopyranosyl-(1->3)}-(alpha-L-arabinopyranosyl)]jujubogenin Natural products CC(C)=CC1CC(C)(O)C2C3CCC4C5(C)CCC(OC6OCC(O)C(OC7OC(CO)C(O)C(O)C7O)C6OC6OC(CO)C(O)C6O)C(C)(C)C5CCC4(C)C33COC2(C3)O1 RANQPHKSRUUPKK-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 206010000117 Abnormal behaviour Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 1
- BZXINCMCFVKGKB-UHFFFAOYSA-N Amarogentin Natural products OCC1OC(OC2OC=C3C(CCOC3=O)C2C=C)C(OC(=O)c4cc(O)cc(O)c4c5cccc(O)c5)C(O)C1O BZXINCMCFVKGKB-UHFFFAOYSA-N 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 240000004244 Cucurbita moschata Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 241000371652 Curvularia clavata Species 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 206010054089 Depressive symptom Diseases 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 240000005717 Dioscorea alata Species 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010060378 Hyperinsulinaemia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000408747 Lepomis gibbosus Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000009811 Momordica charantia Nutrition 0.000 description 1
- 235000009812 Momordica cochinchinensis Nutrition 0.000 description 1
- 240000001740 Momordica dioica Species 0.000 description 1
- 235000018365 Momordica dioica Nutrition 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 description 1
- 208000037158 Partial Epilepsies Diseases 0.000 description 1
- 206010061334 Partial seizures Diseases 0.000 description 1
- CWRVKFFCRWGWCS-UHFFFAOYSA-N Pentrazole Chemical compound C1CCCCC2=NN=NN21 CWRVKFFCRWGWCS-UHFFFAOYSA-N 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- LHNKBXRFNPMIBR-UHFFFAOYSA-N Picrotoxin Natural products CC(C)(O)C1(O)C2OC(=O)C1C3(O)C4OC4C5C(=O)OC2C35C LHNKBXRFNPMIBR-UHFFFAOYSA-N 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 241000382353 Pupa Species 0.000 description 1
- 241000287420 Pyrus x nivalis Species 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 229920000294 Resistant starch Polymers 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 206010049418 Sudden Cardiac Death Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 208000003056 Vitamin B6 deficiency Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 235000010081 allicin Nutrition 0.000 description 1
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 1
- DBOVHQOUSDWAPQ-WTONXPSSSA-N amarogentin Chemical compound O([C@H]1[C@H](O[C@H]2[C@@H]([C@H]3C(C(OCC3)=O)=CO2)C=C)O[C@@H]([C@H]([C@@H]1O)O)CO)C(=O)C1=C(O)C=C(O)C=C1C1=CC=CC(O)=C1 DBOVHQOUSDWAPQ-WTONXPSSSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 229940003871 calcium ion Drugs 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- MKJXYGKVIBWPFZ-CEOVSRFSSA-L calcium;(2s)-2-hydroxypropanoate Chemical compound [Ca+2].C[C@H](O)C([O-])=O.C[C@H](O)C([O-])=O MKJXYGKVIBWPFZ-CEOVSRFSSA-L 0.000 description 1
- MWKXCSMICWVRGW-UHFFFAOYSA-N calcium;phosphane Chemical compound P.[Ca] MWKXCSMICWVRGW-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 230000035603 choleresis Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- GRWVQDDAKZFPFI-UHFFFAOYSA-H chromium(III) sulfate Chemical compound [Cr+3].[Cr+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRWVQDDAKZFPFI-UHFFFAOYSA-H 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001787 epileptiform Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 239000004222 ferrous gluconate Substances 0.000 description 1
- 235000013924 ferrous gluconate Nutrition 0.000 description 1
- 229960001645 ferrous gluconate Drugs 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 201000007186 focal epilepsy Diseases 0.000 description 1
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003451 hyperinsulinaemic effect Effects 0.000 description 1
- 201000008980 hyperinsulinism Diseases 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000002109 interictal effect Effects 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical group [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- 229930192286 jujuboside Natural products 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 239000001755 magnesium gluconate Substances 0.000 description 1
- 235000015778 magnesium gluconate Nutrition 0.000 description 1
- 229960003035 magnesium gluconate Drugs 0.000 description 1
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 description 1
- 239000011683 manganese gluconate Substances 0.000 description 1
- 235000014012 manganese gluconate Nutrition 0.000 description 1
- 229940072543 manganese gluconate Drugs 0.000 description 1
- OXHQNTSSPHKCPB-IYEMJOQQSA-L manganese(2+);(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Mn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OXHQNTSSPHKCPB-IYEMJOQQSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 150000004712 monophosphates Chemical class 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 230000008587 neuronal excitability Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- GSSMIHQEWAQUPM-AOLPDKKJSA-N ovalbumin peptide Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CN=CN1 GSSMIHQEWAQUPM-AOLPDKKJSA-N 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000010627 oxidative phosphorylation Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000035778 pathophysiological process Effects 0.000 description 1
- 229960005152 pentetrazol Drugs 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- VJKUPQSHOVKBCO-AHMKVGDJSA-N picrotoxin Chemical compound O=C([C@@]12O[C@@H]1C[C@]1(O)[C@@]32C)O[C@@H]3[C@H]2[C@@H](C(=C)C)[C@@H]1C(=O)O2.O=C([C@@]12O[C@@H]1C[C@]1(O)[C@@]32C)O[C@@H]3[C@H]2[C@@H](C(C)(O)C)[C@@H]1C(=O)O2 VJKUPQSHOVKBCO-AHMKVGDJSA-N 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 229960004839 potassium iodide Drugs 0.000 description 1
- 235000007715 potassium iodide Nutrition 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 235000020236 pumpkin seed Nutrition 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 235000021254 resistant starch Nutrition 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 230000008925 spontaneous activity Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000000946 synaptic effect Effects 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- JFJZZMVDLULRGK-URLMMPGGSA-O tubocurarine Chemical compound C([C@H]1[N+](C)(C)CCC=2C=C(C(=C(OC3=CC=C(C=C3)C[C@H]3C=4C=C(C(=CC=4CCN3C)OC)O3)C=21)O)OC)C1=CC=C(O)C3=C1 JFJZZMVDLULRGK-URLMMPGGSA-O 0.000 description 1
- 229960001844 tubocurarine Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/25—Synthetic polymers, e.g. vinylic or acrylic polymers
- A23L33/26—Polyol polyesters, e.g. sucrose polyesters; Synthetic sugar polymers, e.g. polydextrose
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pediatric Medicine (AREA)
- Inorganic Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention provides a kind of epilepsy tailored version clinical nutrition formula, including following component and its parts by weight:10 22 parts of protein, 32 55 parts of fat, 6 25 parts of carbohydrate, 79 parts of dietary fibers, 0.6 1.2 parts of macroelements, 0.01 0.04 parts of trace elements, 0.005 0.03 parts of liposoluble vitamins, 0.008 0.2 parts of water soluble vitamins, 0.05 1 parts of meals elite, 0.06 2 parts of integration of drinking and medicinal herbs ingredients and 0.005 2 parts of new resource foods;The present invention also provides a kind of preparation methods of above-mentioned clinical nutrition formula.The present invention can either effectively treat epilepsy syndromes, and can alleviate side effect caused by high fat diet therapy.
Description
Technical field
The present invention relates to special medicine purposes formula food field more particularly to a kind of epileptic's tailored version clinical nutritions
Formula and preparation method thereof.
Background technology
Epilepsy (epilepsy) is a kind of disease of brain, its main feature is that persistently there are epilepsy recurrent exerbations in brain tissue
Neurological susceptibility and thus caused nerve biochemistry, cognition, psychology and societal consequence.At present, there are about 50 × 106 epilepsies in the whole world
Patient, wherein 80% in developing country, about more than 9 × 106 example patient of China, still newly-increased more than 450 × 103 examples, living at present every year
Dynamic venereal disease example about 6.50 × 106, wherein rural area account for 2/3, and treatment gap is up to 70%.The therapy of epilepsy is still at present
So based on Long-term Oral antiepileptic (AEDs), especially some intractable epilepsy types generally require multi-medicament connection
Treatment is closed, and may be taken medicine throughout one's life.
Epilepsy is a kind of nervous system syndrome, have the characteristics that suddenly generation, recurrent exerbation, clinical manifestation for movement,
The different degrees of obstacle of the generations such as sensation, consciousness, autonomic nerve, spirit, but it is inherently cerebral neuron paradoxical discharge
And then cause of short duration brain function not normal.Current medical level can't cure the disease completely, mostly based on control.In recent years
The research come shows the paradoxical discharge of this neuron and neurotransmitter, ion channel, Deiter's cells, synaptic contact, something lost
It passes and immune etc. exception has substantial connection.
Antiepileptic Endocrine and human metabolism function have a variety of harmful effects.For example, valproic acid therapeutic process
In there is serum insulin level rise, weight increases and hyperinsulinemia.All antiepileptics are to thyroid hormone
Secretion have an impact.Easy concurrent secondary hyperthyroidism, exchanging magnesium in body during hyperthyroidism increases, and urine row's magnesium increases, thyroxine energy
Thyroxine is excessive when directly stimulating the operating of magnesium in cell and causing magnesium negative balance and hyperthyroidism, increases Na+-K+-ATP enzymes
Activity promotes oxidative phosphorylation, and oxygen consumption and heat production increase, and cause magnesium metabolic disorder.
Long-term use of antiepileptic can also result in osteoporosis.For example, it can be increased by the antiepileptic of enzyme induction
Add the metabolism of liver vitamin D, reduce Calcium-ion absorption;Rather than the antiepileptic (such as sodium vedproate) of enzyme induction can lead to
It crosses the synthesis of 2 vitamine D3s of reduction 1,25- (OH) and declines osteoblast function.Accelerate the catabolism of activated vitamin D,
Cause that activated vitamin D is substantially reduced and Ca,P metabolism is disorderly, cause secondary hyperthyroidism, make bone metabolism disturbance,
Bone density reduces.
Long-term use of antiepileptic may make part intractable epilepsy infant occur or aggravate its abnormal behavior and spirit
Symptom, for example, enhancing γ-aminobutyric acid (GABA) activity antiepileptic can making patients mental symptom, especially
Depressive symptom.
The study found that valproic acid has certain influence to patient's sexual function.One male's intractable epilepsy to taking valproic acid
The clinical observation of epilepsy patient shows the patients serum's androgen levels rise for having 60% respectively, 50% patient's testosterone levels liter
It is high.Moreover, the risk that the women epileptic for receiving valproic acid treatment suffers from more ovary sample syndromes increases.
High fat diet as treatment epilepsy report can trace back to earliest in the early 1920s, at present high fat diet
Through the optional treatment that treatment of intractable epilepsy is classified as by various countries' guide.High fat diet is a kind of high in fat, appropriate protein, low-carbon
Hydrate diet, by forcing human body burn fat and non-carbohydrate, simulation starvation.Simply, it is exactly more
Grease is eaten, eats rice and flour grain less.So that insulin reduces, glycogen is depleted, and adipose conversion is ketoboidies, and is supplied for body and brain
Energy.Scientist speculates that brain is converted into from glucose energy supply by ketoboidies, and neuronal excitability and electric discharge can be caused to reduce, inhibited
Acidic amino acid is horizontal to be increased, so as to reduce epileptic attack.However, compared with comprehensive epilepsy, high fat diet is to partial insane
Epilepsy may less effective.
Clinical treatment epilepsy is still based on oral antiepileptic at present, takes orally the pair there are many antiepileptics
Effect, high fat diet clinically treats epilepsy, there is limitation, only effective to partial epilepsy, and high fat diet also has ignored
Influence of other nutrients to epileptic attack.Western medical treatment epileptics relies primarily on antiepileptic, secondary although it is rapid to work
Act on more, the compliance and tolerance of patient is poor.In recent years, clinical research is found, this disease of Chinese traditional treatment has definite effect
Fruit, few side effects, but it is slower to work.
For this purpose, epilepsy syndromes can either be alleviated by developing, and needed nutrient matter, the immunity of organisms for enhancing patient can be supplemented
Nutritional formulas be that there is important value and wide market.
The content of the invention
The defects of it is an object of the invention to overcome in the prior art, provides a kind of epileptic's tailored version clinical nutrition and matches somebody with somebody
Side and preparation method thereof according to the clinical nutrition feature of epilepsy, particularly children with intractable epilepsy, uses high protein high in fat
Matter low-carb simulates starvation using high fat diet, effectively treats epilepsy syndromes;Appropriate supplement magnesium simultaneously, calcium,
B family vitamin and vitamin D can enhance immunity of organisms, promote brain blood Xun Huan, further treat epilepsy syndromes, and
Side effect caused by high fat diet therapy can be alleviated.
To achieve the above object, the present invention adopts the following technical scheme that:
First purpose of the present invention is to provide a kind of epilepsy tailored version clinical nutrition formula, including following component and its again
Measure number:10-22 parts of protein, 32-55 parts of fat, 6-25 parts of carbohydrate, 7-9 parts of dietary fibers, 0.6-1.2 parts of constants
Element, 0.01-0.04 parts of trace elements, 0.005-0.03 parts of liposoluble vitamins, 0.008-0.2 parts of water soluble vitamins,
0.05-1 parts of meals elite, 0.06-2 parts of integration of drinking and medicinal herbs ingredients and 0.005-2 parts of new resource foods.
Preferably, the protein be PURE WHEY, it is soybean protein isolate, hydrolysis Isin glue collagen, whole milk powder, complete
At least one of powdered egg, lactoferrin, colostrum, amino acid, protein peptides.
Wherein, the amino acid is L-lysine-Pidolidone, Pidolidone, L-arginine, L-Trp, L- paddy ammonia
At least one of amide, taurine, Valine, l-Isoleucine, L-Leu;The protein peptides for soybean oligopeptide,
At least one of wheat protein peptide, pupa albumen peptide, ocean fish oligopeptide powder, laughable peptide, amino peptide, ovalbumin peptide.
Preferably, it is described fat for saturated fatty acid, polyunsaturated fatty acid, monounsaturated fatty acids, OPO structured lipids,
At least one of DHA, EPA, ARA, phosphatide.
Preferably, the carbohydrate is fructose, in rock sugar, lactose, maltodextrin, tapioca, resistant starch
At least two.
Preferably, the dietary fiber be inulin, it is konjaku flour, galactooligosaccharide, oligofructose, oligoisomaltose, big
At least one of beans polysaccharide, cyclodextrin, resistant dextrin, soybean fiber.
Preferably, the macroelement for calcium citrate, L-calcium lactate, calcium monohydrogen phosphate, K-IAO, sodium citrate and
At least one of magnesium gluconate.
Preferably, the trace element is ferrous gluconate, potassium iodide, zinc gluconate, sodium selenite, gluconic acid
At least one of copper, chromium sulfate, manganese gluconate and sodium molybdate.
Preferably, the liposoluble vitamin is vitamin A, beta carotene, vitamin D3, vitamin E, vitamin K1In
At least one.
Preferably, the water soluble vitamin is vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin C,
At least one of pantothenic acid, folic acid, niacin, choline, inositol, biotin.
Preferably, the meals elite for cereal, beans, potato, greengrocery, Homonemeae, nut-seed class, fish and shrimp,
At least one of poultry meat, fruits.
Wherein, the cereal is selected from rice meal, millet powder, black rice flour, coixlacrymajobi powder, corn flour, wheat germ powder, oat
At least one of powder, buckwheat;The beans in peameal, mung bean flour, black bean powder, red bean powder, soy meal at least
It is a kind of;The potato is mainly made of common yam rhizome powder;The greengrocery be selected from carrot meal, white radish powder, pumpkin powder, spinach powder, kind
At least one of eggplant powder, broccoli powder, balsam pear powder;The Homonemeae in mushroom powder, Kelp Powder and white fungus powder at least
It is a kind of;The nut-seed class is mainly made of pumpkin seed powder and lotus nut starch;The fish and shrimp are selected from salmon powder and cod meal
At least one of;The poultry meat is selected from least one of chicken meal, powdered beef and pig kidney powder;The fruits are selected from
At least one of red date powder, longan powder, apple powder, cherry powder, citrus powder, pyrus nivalis powder.
Preferably, the integration of drinking and medicinal herbs ingredient be Poria cocos, it is spina date seed, peach kernel, Chinese yam, oyster, black pepper, oyster, sweet
At least one of grass;More preferably Poria cocos, spina date seed, peach kernel, Chinese yam, oyster, black pepper.
Preferably, the new resource food is first milk basic protein, γ-aminobutyric acid, chitosan oligosaccharide, eucommia Bark male flower, the leaf of bamboo
In flavones, casein phosphopeptide, avenabeta glucosan, yeast beta-dextran, newborn mineral salt, pueraria root powder, Rosa roxburghii Tratt, xylo-oligosaccharide
It is at least one;More preferably γ-aminobutyric acid.
Above-mentioned nutrient formulation may also include 0.1-3 parts of natural plants compounds.
Preferably, the natural plants compound is l-cn, Glucosamine, oligofructose, lutein, plant steroid
At least one of alcohol, lycopene, resveratrol, allicin;More preferably l-cn.
Above-mentioned nutrient formulation may also include nucleotide;The nucleotide is 5 ' monophosphate cytidines.
Second object of the present invention is to provide a kind of preparation method of above-mentioned epileptic's tailored version clinical nutrition formula,
It includes the following steps:
Step 1, fat powder, liposoluble vitamin powder and water soluble vitamin powder are prepared using micro-capsule embedding techniques
End;
Step 2, carried, be spray-dried and sifting step prepares integration of drinking and medicinal herbs component powders using crushing, alcohol extracting, water;
Step 3, by the protein of predetermined weight, carbohydrate, dietary fiber, macroelement, trace element, meals essence
China, natural plants compound and new resource food are prepared into the powder that grain size is 150~250 μm respectively;
Step 4, powder prepared by step 1~3 is sterilized after mixing spare;
Step 5, the mixed powder of step 4 is prepared by nutrient powder, nutrition emulsion, capsule according to conventional technical means
At least one of agent, tablet, pill or oral liquid;
Wherein, the order of step 1~3 can be replaced mutually.
Finally, the present invention provides a kind of product prepared by above-mentioned puerperal abdominal flatulence gas tailored version clinical nutrition formula, including
Nutrient powder, nutrition emulsion, capsule, tablet, pill, oral liquid etc..
Preferably, in the step 5, suitable food thickening agent and food additives are optionally increased.
Wherein described food thickening agent is guar gum, xanthans, locust bean gum, konjac glucomannan, pectin, carragheen, agar, bright
At least one of glue, Arabic gum;The food additives are at least one in Aspartame, food flavor fragrance, brown sugar
Kind.
More preferably described food thickening agent is carragheen, Arabic gum, guar gum;The food additives are A Siba
Sweet tea, food flavor fragrance.
Preferably, the step 1-5 is both needed to carry out under the protection of inert gas, to prevent the danger of powder explosion
Danger.
Preferably, the preparation process of the integration of drinking and medicinal herbs component powders is as follows:Using pulverizer to predetermined weight number
Raw material crushes, and the raw material of crushing is placed in container, adds in 3~8 times of the water that weight is raw material weight, carries out immersion 3
~4 it is small when, then carry out 30~60min of decoction to soak, filtering removal raw material leaves and takes decoction liquor, decoction liquor is sprayed
Mist is dried, and integration of drinking and medicinal herbs component powders are prepared with 60~80 mesh sieves point.
Preferably, the specific implementation step of the micro-capsule embedding techniques of the fat is as follows:A) wall material aqueous solution is prepared:Take wheat
Bud dextrin, soybean protein isolate, whole-fat milk powder, dietary fiber, inulin, PURE WHEY, oligoisomaltose, soybean fiber,
Arabic gum, candy sugar powder and water stir evenly, and obtain wall material aqueous solution;B) monoglyceride is taken and be dissolved in grease;C) by tween
80 are dissolved in wall material aqueous solution;D) liquid of blend step b) and step c), obtains mixed solution;E) stabilizer agar is added
In mixed solution, constant volume, high speed dispersion under 20000r/min;F) homogenization pressure is 25MPa, and homogeneous emulsus is made in homogeneous 3 times
Liquid;G) emulsion obtained is spray-dried, inlet air temperature is 195 DEG C, and leaving air temp is 80 DEG C, collects and obtains fatty powder
End.
Preferably, the micro-capsule embedding techniques of the vitamin is as follows:By the fat-soluble of predetermined weight number
Vitamin selects carragheen, Arabic gum to carry out 2 emulsifying homogeneous processing under high pressure, emulsification is equal as wall material as core
The matter time is 10~15min, then carries out instantaneous drying of spraying, and liposoluble vitamin powder is prepared with 60~80 mesh sieves point;It will
The water soluble vitamin of predetermined weight number selects maltodextrin, lipoprotein to be uniformly mixed, spraying as wall material as core
It is instantaneous dry, prepare water soluble vitamin powder with 60~80 mesh sieves point.
High fat diet be a fat at high proportion, the low ratio of carbohydrate, protein and other nutrients are suitably matched somebody with somebody
Square diet, other states for simulating human body starvation, can effectively treat children with intractable epilepsy.It treats the mechanism of epilepsy
For:
1. change the energetic supersession mode of brain.
2. change cell characteristics, reduce excitability and buffer epileptiform discharges.
3. changing neurotransmitter, cynapse is transferred, the function of neuromodulator.
4. changing the extracellular environment of brain, excitability and synchronism are reduced.
High fat diet changes human body regular diet structure and energy supply source, and body and brain are required for an adaptation
The process of this variation, is during which likely to occur the malaise symptoms such as headache, weak, diarrhea, vomiting, it is necessary to which 4 weeks~8 weeks just adapt to
This process;And although the change being metabolized in vivo is beneficial to the stabilization of cerebral nerve cynapse, may also be brought to other systems
Side effect, such as the side effects such as osteoporosis, fracture, abnormal bone metabolism, body immunity decline.Being used in the present invention includes
The nutrition of unrighted acid, at high proportion calcium, multivitamin (especially vitamin B), integration of drinking and medicinal herbs ingredient, new resource food
Formula can effectively treat epilepsy syndromes, alleviate side effect caused by high fat diet therapy.
Being used in the present invention includes the integration of drinking and medicinal herbs ingredient of Poria cocos, spina date seed, peach kernel, Chinese yam, oyster, black pepper, on
Stating after components compatibility synergy plays an important role of to calm the nerves that calm, enhancing is physical, clearing heat and detoxicating, replenishes the calcium, enhances body immunity.
Poria cocos mild in medicine property and, can invigorating the spleen, it is thin and weak to those prolonged illness, lose the appetite or have fatigue and asthenia, the deficiency of vital energy of diarrhea concurrently
The weak patient of spleen helps spleen QI invigorating;Can mental-tranquilization, have sedation;Can relax gastrointestinal smooth muscle, tool
Play the role of promoting digestion;Also there is the effect for enhancing body immune simultaneously, suitable for causing machine because of high fat diet therapy
The epileptic that body immunocompetence declines.
Spina date seed is sweet in flavor, sour, mild-natured, fat oil containing volume and protein, and containing sterol, triterpenes, jujuboside, more
Measure vitamin C;There are calmness, hypnosis, analgesia, anticonvulsant action;There is certain antihypertensive effect, suitable for deficiency of YIN-blood, palpitaition is seized with terror
It is sad, insomnia forgetfulness;Body void hidrosis;The symptoms such as headache, weak can be alleviated.
Peach kernel bitter but sweet flavor and it is mild-natured, the heart, liver, large intestine can be entered, promoting blood circulation effect is very wide, additionally can effectively supplement body
The energy of body and containing carbohydrate, carbohydrate, can contribute to provide energy, and Semen Persicae extract rapidly for body
Necrosis of liver cells denaturation and fibrosis are suffered from improving in various degree, also there is certain protective effect for liver, fit
For causing the symptoms such as breathes hard, body immunity decline because of high fat diet therapy.
Chinese yam, it is sweet in flavor, it is mild-natured, there is tonifying spleen nourishing the stomach, the benefits of engender liquid and benefic lung, kidney tonifying puckery essence, rich in 18 kinds of amino acid and
More than 10 kind trace elements and other minerals, so having strengthening the spleen and stomach, tonifying lung kidney, tonifying middle-Jiao and Qi, invigorating the spleen qi-restoratives, reinforce the kidney beneficial essence, benefit
The effects that heart and tranquilizing mind;Rich in calcium in Chinese yam, to injury of the tissues damage bone, osteoporosis, loss of tooth has the effect of high;Simultaneously rich in more
Kind vitamin, amino acid and minerals can prevent Human Lipid Metabolism exception, there is enhancing body immunity, what invigorating heart was calmed the nerves
Effect;Suitable for symptoms such as the headache caused by high fat diet therapy, the declines of weak, abnormal bone metabolism, body immunity.
The liver glycogen of oyster exist in the liver and muscle of stored energy, division, regeneration, the work of red blood cell with cell
Property suffer from very deep relation, liver function can be improved, set up, enhancing muscle power;The contained taurine in oyster
It can promote choleresis, exclude the neutral fat being deposited in liver, improve the detoxication of liver, so raw ketone can be alleviated
The side effect that the drink high in fat of diet is brought improves physical function.
Black pepper is rich in containing vitamin A, vitamin B2, vitamin C, pipering, volatile oil, starch, thiamine, copper,
Iron, zinc, ketone, alcohol, enzyme etc., acrid flavour, property heat, enter stomach, large intestine channel;There is the effect of warming the middle warmer and descending qi, dissolving phlegm is detoxified, it is cold gastral cavity abdomen can be treated
Bitterly, the symptoms such as gastric disorder causing nausea, vomiting, diarrhea, suitable for the malaise symptoms such as diarrhea, vomiting caused by high fat diet therapy.
The present invention compared with prior art, is had the following technical effect that using above-mentioned technical proposal:
Epileptic's tailored version clinical nutrition formula of the present invention is polyunsaturated fatty acid including ω -3, is beneficial to reduce
The viscosity of blood promotes brain blood Xun Huan, reduces convulsions, alleviates children with intractable epilepsy symptom;
Add medium chain triglyceride, can while identical energy is provided produced more ketoboidies, effectively antagonize small
Youngster's intractable epilepsy;
Monounsaturated fatty acids (MUFA) at high proportion, can reduce the generation of arrhythmia cordis and cardiac sudden death, and pre- child-resistant is insane
Epilepsy is died suddenly;
Strengthen taurine, be capable of providing human body oxidation resistance, enhance immunity of organisms;
Strengthen calcium, calcium is the main component for forming children's bone and tooth, can promote upgrowth and development of children, and it is close to improve bone
Degree;Low blood calcium is also one of the reason for epilepsy is caused to occur, therefore supplements enough calcium and can avoid epilepsy to a certain extent
The generation of illness;
Strengthen iron, zinc, iron is the important element for forming hemoglobin, being capable of the pre- postoperative hypoferric anemia of child-resistant;Zinc is
One of the essential trace elements of the human body is the constituent of a variety of enzymes, widely participates in various metabolic activities, be conducive to skin
The normal growth of skin, bone and tooth promotes children's appetite, helps to enhance children physique, so as to which the body for enhancing children is exempted from
Epidemic disease ability;
A variety of water solubility type vitamin rational proportions, vitamin C can enhance the metabolism of nerve cell, to lipid metabolism
Also have a certain impact, help to improve the speed of cholesterol transformation cholic acid, strengthen vascular toughness;B family vitamin is that body is more
The coenzyme of kind important biomolecule enzyme, participates in the synthesis and metabolism of many kinds of substance, especially neurotransmitter and quenched synthesis and release,
Wherein vitamin B6Related with a kind of generation of γ-aminobutyric acid (inhibitory neurotransmitter), research shows VitB in serum6Contain
Amount reduction is related with the generation of epilepsy, so one of the reason for Vitamin B6 deficiency may be epileptic attack;
A variety of fat-soluble type vitamin rational proportions, vitamin D can promote the absorption of calcium phosphorus, maintain calcium, phosphorus in blood
Level promotes the growth of children's bone and tooth, and system is maintained to stablize, and alleviates epileptic attack;Vitamin E has inhibition brain tissue oxygen
Change acts on, i.e. antioxidation, can remove the free radical of toxicity in humans;It or a kind of membrane stabilizer simultaneously, can be to prevent
Only the permeability of brain cell increases, and plays the role of preventing convulsive seizure;
Integration of drinking and medicinal herbs ingredient is added, can effectively alleviate epilepsy syndromes, pipering in pepper powder extracts is caused less than half
Under dead dosage, to rat and mouse caused by electroconvulsive shock, pentylenetetrazole, picrotoxin, strychnine, tubocurarine and sodium glutamate
Convulsions has different degrees of antagonism, and can reduce the death rate of animal, reduces infantile convulsion number;In oyster extract
Oyster aldehyde have apparent sedation to small white mouse, show as spontaneous activity reduction, can make children epilepsy state alleviate;Peach kernel
Amarogentin in extract generates hydrogen cyanide and benzaldehyde after enteric bacteria hydrolyzes, the former has central antitussive effect;Acid
Composition of alkaloids can make that the time fainted from fear occurs in mouse and the death time is obviously prolonged in jujube kernel extract;
0.1 part of new resource food γ-aminobutyric acid is added, γ-aminobutyric acid is a kind of inhibitory neurotransmitter, not only right
Three continuous pathophysiological processes of difference of children epilepsy breaking-out play an important role, while have and promote pituitary growth hormone
Effect, be one of Core amino acids needed for children's upgrowth and development.
The present invention using the proportioning of general equilibrium, while is added with tranquilizing the mind town by selecting rational basal nutrient element
The specific nutrients such as quiet, enhancing is physical, clearing heat and detoxicating, new resource food, the integration of drinking and medicinal herbs ingredient of enhancing body immunity, and
Adjust its proportioning with basal nutrient element carry out compatibility synergy, comprehensively supplement using high fat diet treat epileptic needed for must
Must nutritional ingredient, and the nutrient formulation is easier the effect of being absorbed by people digest, giving full play to its each component, while has and carry
The enhancing effect of produced more ketoboidies while for identical energy, so as to reach the function of preferably treating epilepsy, and
Side effect caused by high fat diet therapy can be alleviated.
Specific embodiment
The present invention provides a kind of epileptic's tailored version clinical nutrition formula, including following component and its parts by weight:
10-22 parts of protein, 32-55 parts of fat, 6-25 parts of carbohydrate, 7-9 parts of dietary fibers, 0.6-1.2 parts of macroelements,
0.01-0.04 parts of trace elements, 0.005-0.03 parts of liposoluble vitamins, 0.008-0.2 parts of water soluble vitamins, 0.05-1 parts
Meals elite, 0.06-2 parts of integration of drinking and medicinal herbs ingredients, 0.1-3 parts of natural plants compounds and 0.005-2 parts of new resource foods.
With reference to embodiment, the specific embodiment of the present invention is further described.Following embodiment is only used for more
Add and clearly demonstrate technical scheme, and be not intended to limit the protection scope of the present invention and limit the scope of the invention.
Embodiment 1
Epileptic's tailored version clinical nutrition formula of the present invention includes PURE WHEY 6.7g, soybean protein isolate
3.33g, whole milk powder 11.4g, bovine colostrum 0.17g, ocean fish oligopeptide 0.2g, taurine 0.13g;Olive oil 13g, soybean
Oily 21g, coconut oil 13g, perilla herb oil 3g, medium chain triglyceride 1.7g;Maltodextrin 4.58g, rock sugar 2.33g;Aqueous soluble dietary
Fiber 5.33g, soybean fiber 3.33g;Calcium 0.53g, phosphorus 0.24g, potassium 0.1g, sodium 0.07g, magnesium 0.174g in macroelement;It is micro-
Iron 0.015g, zinc 0.013g in secondary element;Vitamin A 0.0007g, beta carotene 0.017g, vitamin D3 0.000001g、
Vitamin E 0.009g;Vitamin B10.001g, vitamin B20.001g, vitamin B60.001g, vitamin B12
0.000005g, vitamin C 0.163g, pantothenic acid 0.003g, folic acid 0.00013g, niacin 0.0124g;Carrot meal 0.2g, red bean
Powder 0.2g, broccoli powder 0.2g, white fungus powder 0.2g, Poria cocos 0.01g, spina date seed 0.01g, peach kernel 0.01g, Chinese yam 0.01g, oyster
0.01g, black pepper 0.01g, γ-aminobutyric acid 0.01g.
Embodiment 2
Epileptic's tailored version clinical nutrition formula of the present invention includes PURE WHEY 6.7g, soybean protein isolate
3.33g, whole milk powder 11.4g, bovine colostrum 0.17g, ocean fish oligopeptide 0.2g, taurine 0.13g;Olive oil 13g, soybean
Oily 21g, coconut oil 13g, perilla herb oil 3g, medium chain triglyceride 1.7g;Maltodextrin 4.58g, rock sugar 2.33g;Aqueous soluble dietary
Fiber 5.33g, soybean fiber 3.33g;Calcium 0.53g, phosphorus 0.24g, potassium 0.1g, sodium 0.07g, magnesium 0.174g in macroelement;It is micro-
Iron 0.015g, zinc 0.013g in secondary element;Vitamin A 0.0007g, beta carotene 0.017g, vitamin D3 0.000001g、
Vitamin E 0.009g;Vitamin B10.001g, vitamin B20.001g, vitamin B60.001g, vitamin B12
0.000005g, vitamin C 0.163g, pantothenic acid 0.003g, folic acid 0.00013g, niacin 0.0124g;Carrot meal 0.2g, red bean
Powder 0.2g, broccoli powder 0.2g, white fungus powder 0.2g, Poria cocos 0.2g, spina date seed 0.2g, peach kernel 0.2g, Chinese yam 0.2g, oyster
0.1g, black pepper 0.1g, γ-aminobutyric acid 0.03g.
Embodiment 3
Epileptic's tailored version clinical nutrition formula of the present invention includes PURE WHEY 6.7g, soybean protein isolate
3.33g, whole milk powder 11.4g, bovine colostrum 0.17g, ocean fish oligopeptide 0.2g, taurine 0.13g;Olive oil 10g, soybean
Oily 11g, coconut oil 10g, perilla herb oil 1g, medium chain triglyceride 1.7g;Maltodextrin 22.58g, rock sugar 2.33g;Aqueous soluble dietary
Fiber 5.33g, soybean fiber 3.33g;Calcium 0.53g, phosphorus 0.24g, potassium 0.1g, sodium 0.07g, magnesium 0.174g in macroelement;It is micro-
Iron 0.015g, zinc 0.013g in secondary element;Vitamin A 0.0007g, beta carotene 0.017g, vitamin D3 0.000001g、
Vitamin E 0.009g;Vitamin B10.001g, vitamin B20.001g, vitamin B60.001g, vitamin B12
0.000005g, vitamin C 0.163g, pantothenic acid 0.003g, folic acid 0.00013g, niacin 0.0124g;Carrot meal 0.2g, red bean
Powder 0.2g, broccoli powder 0.2g, white fungus powder 0.2g, Poria cocos 0.01g, spina date seed 0.01g, peach kernel 0.01g, Chinese yam 0.01g, oyster
0.01g, black pepper 0.01g, γ-aminobutyric acid 0.01g.
Embodiment 4
The preparation method that a kind of epileptic's tailored version clinical nutrition as described in 1~embodiment of embodiment 3 is matched somebody with somebody is as follows:
1) powdered oil (powder fat) is prepared:
A) wall material aqueous solution is prepared:Take 8 grams of maltodextrin, 4 grams of soybean protein isolate, 11 grams of whole-fat milk powder, dietary fiber 2
Gram (resistant dextrin), 0.5 gram of inulin, 5 grams of PURE WHEY, 0.5 gram of oligoisomaltose, 1 gram of soybean fiber, Arabic gum
0.2 gram, 2 grams of candy sugar powder, 50 milliliters of water stirs evenly and (has ready conditions and heat while stirring to 60 DEG C, keep 30 minutes postcoolings extremely
Room temperature).
B) 0.1 gram (total solid concentration is 0.2%) is taken uniformly to be dissolved in (olive oil in 17.38 milliliters of greases monoglyceride
4.4 milliliters, it is 7.2 milliliters of soybean oil, 4.4 milliliters of coconut oil, 1.0 milliliters of perilla herb oil, 0.3 milliliter of medium chain triglyceride, single double sweet
0.08 milliliter of oil and fat acid esters).
C) 0.1 gram (total solid concentration is 0.2%) is taken uniformly to be dissolved in wall material aqueous solution Tween 80.
D) the wall material aqueous solution of the mixed plant grease and addition Over emulsfication agent Tween 80 of Over emulsfication agent monoglyceride will be added
It is sufficiently mixed.
E) addition stabilizer agar takes 0.1 gram (total solid concentration be 0.2%) to be settled into after mixed solution with water
200 milliliters (total solid concentration be 25%), high speed dispersion 2 minutes under 20000r/min.
F) homogenization pressure is 25MPa, and homogeneous emulsion is made in homogeneous 3 times (every time 5 minutes).
G) emulsion obtained is spray-dried, inlet air temperature is 195 DEG C, and leaving air temp is 80 DEG C.Collect powder
Grease (powder fat).
2) integration of drinking and medicinal herbs component powders are prepared:The raw material of predetermined weight number is crushed using pulverizer, will be crushed
Raw material be placed in container, add in weight be raw material weight 3~8 times of water, carry out immersion 3~4 it is small when, then to soak
30~60min of decoction is carried out, filtering removal raw material leaves and takes decoction liquor, decoction liquor is spray-dried, with 60~80 mesh sieves point
Prepare integration of drinking and medicinal herbs component powders;
3) vitamin powder is prepared:Using the liposoluble vitamin of predetermined weight number as core, select carragheen, I
Primary glue carries out 2 emulsifying homogeneous processing, the emulsifying homogeneous time is 10~15min, is then sprayed under high pressure as wall material
It is instantaneous dry, prepare liposoluble vitamin powder with 60~80 mesh sieves point;Using the water soluble vitamin of predetermined weight number as
Core selects maltodextrin, lipoprotein to be uniformly mixed as wall material, spray instantaneous dry, prepared with 60~80 mesh sieves point water-soluble
Property vitamin powder;
4) by the protein of predetermined weight and amino acid, nucleotide, carbohydrate, dietary fiber, macroelement, micro
Element, meals elite, natural plants compound and new resource food are prepared into the powder that grain size is 150~250 μm respectively;
5) mixer that the powder obtained by step 1)~step 4) is sequentially added to cone-type mixer or other forms mixes
Uniformly obtained formula mixture is closed, it is spare after sterilization processing;
6) according to conventional technical means by the formula mixture in step 5) be prepared into nutrient powder, nutrition emulsion, capsule,
At least one of tablet, pill or oral liquid.
In step 6), optionally increase suitable food thickening agent and food additives.The food thickening agent
It is described at least one of guar gum, xanthans, locust bean gum, konjac glucomannan, pectin, carragheen, agar, gelatin, Arabic gum
Food additives are at least one of Aspartame, food flavor fragrance, brown sugar;More preferable carragheen, Arabic gum, Guar
Glue, Aspartame, food flavor fragrance.
Aforesaid operations step is both needed to carry out under the protection of inert gas, such as nitrogen, argon gas, helium etc., to prevent from producing
The danger of green powder explosion.
According to described with the classifications such as powdery, graininess, capsule shape, tablet shape, beverage can be prepared into.
Embodiment 5
The present embodiment verifies influence of the nutrient formulation of the present invention to epileptic.The present embodiment uses embodiment 2
Formula prepare electuary and following comparative examples:
Control group 1:Take commercially available antiepileptic (AEDs) -- sodium vedproate piece;
Comparative example 1:It is polyunsaturated fatty acid not add ω -3, the electuary that remaining component is prepared by the formula of embodiment 2;
Comparative example 2:Medium chain triglyceride is not added, the electuary that remaining component is prepared by the formula of embodiment 2;
Comparative example 3:B family vitamin is not added, the electuary that remaining component is prepared by the formula of embodiment 2;
Comparative example 4:Integration of drinking and medicinal herbs ingredient is not added, the electuary that remaining component is prepared by the formula of embodiment 2.
5 groups of experimental group is set, the epileptic 50 for meeting intractable diagnosis of respective tablets is voluntarily taken in every group of selection,
High fat diet, test period 12 months are started using " progressively transition high fat diet method ".The experimental results are shown inthe following table:
The comparison (n (%)) of clinical efficacy between the different groups of table 1
It cures:After the test period of 12 months, epileptic attack controls completely, and EEG(electrocardiogram) examination recovers normal;
It is effective:Reduction by 75% or interictal extend before relatively treating before seizure trequency is relatively treated>6 months, electroencephalogram
It is obviously improved;
Effectively:Reduction by 50%~75% or breaking-out symptom, which significantly mitigate or break out, before seizure trequency is relatively treated continues
Time shortens more than 50%, and electroencephalogram makes moderate progress;
It is invalid:Seizure trequency, severity, cardinal symptom and electroencephalogram improve equal unobvious.
The comparison (n (%)) of adverse reaction rate between the different groups of table 2
As seen from the above table, the electuary prepared in the present invention by the nutrient formulation of embodiment 2 can effectively alleviate epilepsy hair
The symptom of work, while Western medicine therapy, the complication of traditional high fat diet therapy are reduced, compared with the control group, comparative example 1-3 also has
There is certain effect, but its effect is slightly weaker than nutrient formulation of the present invention.
Specific embodiments of the present invention are described in detail above, but it is intended only as example, it is of the invention and unlimited
It is formed on particular embodiments described above.To those skilled in the art, it is any to the equivalent modifications that carry out of the present invention and
It substitutes also all among scope of the invention.Therefore, the impartial conversion made without departing from the spirit and scope of the invention and
Modification, all should be contained within the scope of the invention.
Claims (9)
1. a kind of epileptic's tailored version clinical nutrition formula, which is characterized in that including following component and its parts by weight:10-
22 parts of protein, 32-55 parts of fat, 6-25 parts of carbohydrate, 7-9 parts of dietary fibers, 0.6-1.2 parts of macroelements, 0.01-
0.04 part of trace element, 0.005-0.03 parts of liposoluble vitamins, 0.008-0.2 parts of water soluble vitamins, 0.05-1 portions of meals
Elite, 0.06-2 parts of integration of drinking and medicinal herbs ingredients, 0.1-3 parts of natural plants compounds and 0.005-2 parts of new resource foods;
Wherein, the new resource food be selected from first milk basic protein, γ-aminobutyric acid, chitosan oligosaccharide, eucommia Bark male flower, bamboo-leaves flavones,
In casein phosphopeptide, avenabeta glucosan, yeast beta-dextran, newborn mineral salt, pueraria root powder, Rosa roxburghii Tratt, xylo-oligosaccharide at least
It is a kind of;
Wherein, the integration of drinking and medicinal herbs ingredient is in Poria cocos, spina date seed, peach kernel, Chinese yam, oyster, black pepper, oyster, Radix Glycyrrhizae
It is at least one.
2. a kind of epileptic's tailored version clinical nutrition formula according to claim 1, which is characterized in that the fat is
At least one in saturated fatty acid, polyunsaturated fatty acid, monounsaturated fatty acids, OPO structured lipids, DHA, EPA, ARA, phosphatide
Kind.
3. a kind of epileptic's tailored version clinical nutrition formula according to claim 1, which is characterized in that the meals are fine
It ties up as inulin, konjaku flour, galactooligosaccharide, oligofructose, oligoisomaltose, soybean polyoses, cyclodextrin, resistant dextrin, big
At least one of beans fiber.
4. a kind of epileptic's tailored version clinical nutrition formula according to claim 1, which is characterized in that described fat-soluble
Vitamin is vitamin A, beta carotene, vitamine D3, vitamin E, vitamin K1At least one of.
A kind of 5. epileptic's tailored version clinical nutrition formula according to claim 1, which is characterized in that the water solubility
Vitamin is vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin C, pantothenic acid, folic acid, niacin, choline, inositol,
At least one of biotin.
A kind of 6. epileptic's tailored version clinical nutrition formula according to claim 1, which is characterized in that the meals essence
At least one in Huawei's cereal, beans, potato, greengrocery, Homonemeae, nut-seed class, fish and shrimp, poultry meat, fruits
Kind.
A kind of 7. epileptic's tailored version clinical nutrition formula according to claim 1, which is characterized in that the new resources
Food is γ-aminobutyric acid.
8. a kind of epileptic's tailored version clinical nutrition formula according to claim 1, which is characterized in that the medicine food is same
Derived components are Poria cocos, spina date seed, peach kernel, Chinese yam, oyster, black pepper.
It is 9. a kind of such as a kind of preparation side of epileptic's tailored version clinical nutrition formula according to any one of claims 1 to 8
Method, which is characterized in that include the following steps:
Step 1, fat powder, liposoluble vitamin powder and water soluble vitamin powder are prepared using micro-capsule embedding techniques;
Step 2, carried, be spray-dried and sifting step prepares integration of drinking and medicinal herbs component powders using crushing, alcohol extracting, water;
Step 3, by the protein of predetermined weight, carbohydrate, dietary fiber, macroelement, trace element, meals elite,
Natural plants compound and new resource food are prepared into the powder that grain size is 150~250 μm respectively;
Step 4, powder prepared by step 1~3 is sterilized after mixing spare;
Step 5, the mixed powder of step 4 is prepared by nutrient powder, nutrition emulsion, capsule, piece according to conventional technical means
At least one of agent, pill or oral liquid;
Wherein, the order of step 1~3 can be replaced mutually.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711331581.7A CN108077911A (en) | 2017-12-13 | 2017-12-13 | A kind of epileptic's tailored version clinical nutrition formula and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711331581.7A CN108077911A (en) | 2017-12-13 | 2017-12-13 | A kind of epileptic's tailored version clinical nutrition formula and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108077911A true CN108077911A (en) | 2018-05-29 |
Family
ID=62175618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711331581.7A Pending CN108077911A (en) | 2017-12-13 | 2017-12-13 | A kind of epileptic's tailored version clinical nutrition formula and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108077911A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109349618A (en) * | 2018-10-23 | 2019-02-19 | 上海奥医生物医药科技有限公司 | Constipation tailored version clinical nutrition formula and preparation method thereof |
CN109497563A (en) * | 2018-10-23 | 2019-03-22 | 上海奥医生物医药科技有限公司 | Leucoderma tailored version clinical nutrition formula and preparation method thereof |
CN109497520A (en) * | 2018-11-15 | 2019-03-22 | 上海奥医生物医药科技有限公司 | A kind of self-closing disease tailored version clinical nutrition composition and preparation method thereof |
CN109601674A (en) * | 2018-12-07 | 2019-04-12 | 入圣生物科技无锡有限公司 | A kind of adjustable human body body and the food of immunity and preparation method thereof |
CN110495606A (en) * | 2019-09-18 | 2019-11-26 | 金建国 | A kind of plant high fat diet formula food |
CN111657497A (en) * | 2020-06-28 | 2020-09-15 | 深圳市捷利康生物科技有限公司 | Ketogenic diet for resisting food protein allergy and preparation method thereof |
CN112471504A (en) * | 2020-12-15 | 2021-03-12 | 济南大学 | Special medical purpose formula food for epileptic and preparation method thereof |
CN112544965A (en) * | 2020-12-31 | 2021-03-26 | 济南大学 | Rose based medical formula food for relieving epilepsy and preparation method thereof |
CN113974157A (en) * | 2021-09-07 | 2022-01-28 | 陕西天承生物科技股份有限公司 | A ketogenic diet with homology of medicine and food for relieving adverse reaction |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106490605A (en) * | 2016-12-23 | 2017-03-15 | 上海奥医生物医药科技有限公司 | A kind of hypertension of pregnancy tailored version clinical nutrition formula and preparation method thereof |
CN106579393A (en) * | 2016-12-23 | 2017-04-26 | 上海奥医生物医药科技有限公司 | Special clinical nutrient formula for diabetes and preparation method thereof |
CN106942748A (en) * | 2017-03-29 | 2017-07-14 | 上海奥医生物医药科技有限公司 | A kind of female acyesis tailored version clinical nutrition formula and preparation method thereof |
CN107242550A (en) * | 2017-06-29 | 2017-10-13 | 上海复旦奥医医学科技有限公司 | A kind of male sterility tailored version clinical nutrition formula and preparation method thereof |
CN107440120A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of children's monophagia and anorexia tailored version clinical nutrition formula particular about food and preparation method thereof |
CN107440121A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of Single Obesity tailored version clinical nutrition formula and preparation method thereof |
-
2017
- 2017-12-13 CN CN201711331581.7A patent/CN108077911A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106490605A (en) * | 2016-12-23 | 2017-03-15 | 上海奥医生物医药科技有限公司 | A kind of hypertension of pregnancy tailored version clinical nutrition formula and preparation method thereof |
CN106579393A (en) * | 2016-12-23 | 2017-04-26 | 上海奥医生物医药科技有限公司 | Special clinical nutrient formula for diabetes and preparation method thereof |
CN106942748A (en) * | 2017-03-29 | 2017-07-14 | 上海奥医生物医药科技有限公司 | A kind of female acyesis tailored version clinical nutrition formula and preparation method thereof |
CN107242550A (en) * | 2017-06-29 | 2017-10-13 | 上海复旦奥医医学科技有限公司 | A kind of male sterility tailored version clinical nutrition formula and preparation method thereof |
CN107440120A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of children's monophagia and anorexia tailored version clinical nutrition formula particular about food and preparation method thereof |
CN107440121A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of Single Obesity tailored version clinical nutrition formula and preparation method thereof |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109349618A (en) * | 2018-10-23 | 2019-02-19 | 上海奥医生物医药科技有限公司 | Constipation tailored version clinical nutrition formula and preparation method thereof |
CN109497563A (en) * | 2018-10-23 | 2019-03-22 | 上海奥医生物医药科技有限公司 | Leucoderma tailored version clinical nutrition formula and preparation method thereof |
CN109497520A (en) * | 2018-11-15 | 2019-03-22 | 上海奥医生物医药科技有限公司 | A kind of self-closing disease tailored version clinical nutrition composition and preparation method thereof |
CN109601674A (en) * | 2018-12-07 | 2019-04-12 | 入圣生物科技无锡有限公司 | A kind of adjustable human body body and the food of immunity and preparation method thereof |
CN110495606A (en) * | 2019-09-18 | 2019-11-26 | 金建国 | A kind of plant high fat diet formula food |
CN111657497A (en) * | 2020-06-28 | 2020-09-15 | 深圳市捷利康生物科技有限公司 | Ketogenic diet for resisting food protein allergy and preparation method thereof |
CN112471504A (en) * | 2020-12-15 | 2021-03-12 | 济南大学 | Special medical purpose formula food for epileptic and preparation method thereof |
CN112544965A (en) * | 2020-12-31 | 2021-03-26 | 济南大学 | Rose based medical formula food for relieving epilepsy and preparation method thereof |
CN113974157A (en) * | 2021-09-07 | 2022-01-28 | 陕西天承生物科技股份有限公司 | A ketogenic diet with homology of medicine and food for relieving adverse reaction |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108077911A (en) | A kind of epileptic's tailored version clinical nutrition formula and preparation method thereof | |
CN107319525A (en) | One kind fat-reducing fat reducing tailored version clinical nutrition formula and preparation method thereof | |
CN106983136A (en) | A kind of puerperium conditioning tailored version clinical nutrition formula and preparation method thereof | |
CN108618129A (en) | Sarcopenia tailored version clinical nutrition formula and preparation method thereof | |
CN106579393A (en) | Special clinical nutrient formula for diabetes and preparation method thereof | |
CN106858620A (en) | A kind of anaemia tailored version clinical nutrition formula and preparation method thereof | |
CN107242550A (en) | A kind of male sterility tailored version clinical nutrition formula and preparation method thereof | |
CN106962912A (en) | A kind of hepatopathy tailored version clinical nutrition formula and preparation method thereof | |
CN106072573A (en) | A kind of it is applicable to the special dietary seafood that old aged muscle decay disease is edible | |
CN106473153A (en) | Full nutrition formula food and preparation method thereof | |
CN108835262B (en) | Modified milk powder for improving memory and preparation method thereof | |
CN109965026A (en) | A kind of formula milk and preparation method thereof promoting child growth | |
CN107440120A (en) | A kind of children's monophagia and anorexia tailored version clinical nutrition formula particular about food and preparation method thereof | |
CN108013454A (en) | Gynaecological imflammation tailored version clinical nutrition formula and preparation method thereof | |
CN107927754A (en) | Tailored version clinical nutrition formula and preparation method thereof is energized during one kind production | |
CN111296584A (en) | Formula yak milk powder for promoting height increase and brain development of children and preparation method thereof | |
CN108013453A (en) | Children's lactose intolerance tailored version clinical nutrition formula and preparation method thereof | |
CN110074397A (en) | A kind of upgrowth and development of children tailored version clinical nutrition formula and preparation method thereof | |
CN107616490A (en) | A kind of postoperative tailored version clinical nutrition formula of children and preparation method thereof | |
CN108013452A (en) | A kind of puerperal abdominal flatulence gas tailored version clinical nutrition formula and preparation method thereof | |
CN107440121A (en) | A kind of Single Obesity tailored version clinical nutrition formula and preparation method thereof | |
CN108669540A (en) | Cerebral apoplexy tailored version clinical nutrition formula and preparation method thereof | |
CN108703365A (en) | Protein allergy tailored version clinical nutrition formula and preparation method thereof | |
CN107373672A (en) | A kind of irregular menstruation women tailored version clinical nutrition formula and preparation method thereof | |
CN107440102A (en) | A kind of climacteric women tailored version clinical nutrition formula and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180529 |